Meeting NewsVideo

VIDEO: Deepak Bhatt, MD, MPH, highlights REDUCE-IT, treating beyond LDL lowering

SAN ANTONIO — In this video exclusive, Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital and professor of medicine at Harvard Medical School, highlights the take-home messages from his keynote lecture at the American Society for Preventive Cardiology Congress on CVD Prevention, which focused on key discoveries from REDUCE-IT and other trials showing benefit of treating patients beyond LDL lowering.

Bhatt, who is a Cardiology Today Editorial Board member, provides an update on recent trials, with emphasis on REDUCE-IT and icosapent ethyl (Vascepa, Amarin), and how the results “fit into the larger context” of CVD prevention.

Watch the video for more.

SAN ANTONIO — In this video exclusive, Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital and professor of medicine at Harvard Medical School, highlights the take-home messages from his keynote lecture at the American Society for Preventive Cardiology Congress on CVD Prevention, which focused on key discoveries from REDUCE-IT and other trials showing benefit of treating patients beyond LDL lowering.

Bhatt, who is a Cardiology Today Editorial Board member, provides an update on recent trials, with emphasis on REDUCE-IT and icosapent ethyl (Vascepa, Amarin), and how the results “fit into the larger context” of CVD prevention.

Watch the video for more.

    See more from American Society for Preventive Cardiology Congress on CVD Prevention